RecruitingNCT06079424

Risk Markers of Arterial Aging. The Paris Prospective Study III-2

Risk Markers of Arterial Aging and Subsequent Risk of Cardiovascular Diseases and Beyond. The Paris Prospective Study III-2

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment

7,500 participants

Start Date

Jun 20, 2025

Study Type

OBSERVATIONAL

Conditions

Arterial Stiffness

Summary

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

Eligibility

Min Age: 60 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying high-precision carotid echo-tracking for people with arterial stiffness. The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years to 95 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.